miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer
Authors:
- 1 April 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 825, 75-84
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1Oncology Reports, 2015
- Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cellsOncotarget, 2015
- STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancerOncogene, 2014
- miR‐185‐3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitroCancer Science, 2014
- MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia-inducible factor-2α pathway in vitro and in vivoMolecular Medicine Reports, 2014
- Molecular Markers for Breast Cancer: Prediction on Tumor BehaviorDisease Markers, 2014
- MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancerWorld Journal of Gastroenterology, 2014
- miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancerMolecular and Cellular Biochemistry, 2013
- MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human gliomaMolecular Cancer, 2011
- MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancersOncogene, 2010